Ferrous Fumarate

富马酸亚铁

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameFerrous Fumarate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsIron deficiencyDrug-Related Side Effects and Adverse ReactionsAnemia, Iron-Deficiency +[4] 
Global Approved IndicationsAnemia, Iron-Deficiency
Approved Indications in ChinaAnemia, Iron-Deficiency
Original Approved Country/TerritoryCanada
Original Approved DateN/A
Country/TerritoryCanadaThailandMexico +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMercury Pharmaceuticals LtdHospital General De MexicoPrince Of Songkla University +[5] 
Inactive CompaniesCairo UniversityNovopharm LtdLondon School Of Hygiene And Tropical Medicine +[4] 
Active IndicationsIron deficiencyDrug-Related Side Effects and Adverse ReactionsAnemia, Iron-Deficiency
Inactive IndicationsAnemia

Other Information

ATC CodeB03AA02B03AD02
Related LinksWikipediaKEGG